144 related articles for article (PubMed ID: 2625032)
21. Natural course of remission in IDDM during 1st yr after diagnosis.
Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
[TBL] [Abstract][Full Text] [Related]
22. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
23. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
[TBL] [Abstract][Full Text] [Related]
25. Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis.
Marner B; Lernmark A; Ludvigsson J; MacKay P; Matsuba I; Nerup J; Rabinovitch A
Diabetes Res; 1985 Sep; 2(5):231-6. PubMed ID: 3905187
[TBL] [Abstract][Full Text] [Related]
26. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.
Landin-Olsson M; Nilsson KO; Lernmark A; Sundkvist G
Diabetologia; 1990 Sep; 33(9):561-8. PubMed ID: 2253834
[TBL] [Abstract][Full Text] [Related]
27. Non-human primate pancreas as a substrate for the detection of islet-cell antibodies in human sera.
Scherbaum WA; Trischler G; Pfeiffer EF
Diabetes Res Clin Pract; 1989 Jun; 7(1):1-5. PubMed ID: 2666065
[TBL] [Abstract][Full Text] [Related]
28. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
29. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
[TBL] [Abstract][Full Text] [Related]
30. Immunogenetic and nutritional profile in insulin-using youth-onset diabetics in Korea.
Huh KB; Lee HC; Kim HM; Cho YW; Kim YL; Lee KW; Lee EJ; Lim SK; Kim DH; Yoon JW
Diabetes Res Clin Pract; 1992 Apr; 16(1):63-70. PubMed ID: 1576933
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
[TBL] [Abstract][Full Text] [Related]
32. Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients.
Spinas GA; Snorgaard O; Hartling SG; Oberholzer M; Berger W
Diabetes Care; 1992 May; 15(5):632-7. PubMed ID: 1516482
[TBL] [Abstract][Full Text] [Related]
33. Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis.
Manna R; Salvatore M; Scuderi F; Papa G; Marietti G; Greco AV; Ghirlanda G; Gambassi G
Diabetes Res; 1988 Nov; 9(3):101-3. PubMed ID: 3072142
[TBL] [Abstract][Full Text] [Related]
34. Relationship between insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus: beta-cell function, islet cell antibody, and haptoglobin in parents of IDDM patients.
Kajio H; Kobayashi T; Nakanishi K; Okubo M; Tsukada T; Nakayama T; Yamada N; Murase T; Yazaki Y; Kosaka K
Metabolism; 1995 Jul; 44(7):869-75. PubMed ID: 7616845
[TBL] [Abstract][Full Text] [Related]
35. Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes.
Kobayashi T; Itoh T; Kosaka K; Sato K; Tsuji K
Diabetes; 1987 Apr; 36(4):510-7. PubMed ID: 3545950
[TBL] [Abstract][Full Text] [Related]
36. High genetic risk for IDDM in the Pacific Northwest. First report from the Washington State Diabetes Prediction Study.
Rowe RE; Leech NJ; Nepom GT; McCulloch DK
Diabetes; 1994 Jan; 43(1):87-94. PubMed ID: 8262322
[TBL] [Abstract][Full Text] [Related]
37. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes.
Fernandez Castañer M; Montaña E; Camps I; Biarnes J; Merino JF; Escriba JM; Nacher V; Rosel P; Soler J
Diabetes Metab; 1996 Oct; 22(5):349-55. PubMed ID: 8896997
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
Kretowski A; Szelachowska M; Kinalska I
Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
[TBL] [Abstract][Full Text] [Related]
39. Proinsulin immunoreactivity in recent-onset IDDM: the significance of insulin antibodies and insulin autoantibodies.
Snorgaard O; Kjems LL; Røder ME; Hartling SG; Dinesen B; Binder C
Diabetes Care; 1996 Feb; 19(2):146-50. PubMed ID: 8718435
[TBL] [Abstract][Full Text] [Related]
40. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.
Keymeulen B; Ling Z; Gorus FK; Delvaux G; Bouwens L; Grupping A; Hendrieckx C; Pipeleers-Marichal M; Van Schravendijk C; Salmela K; Pipeleers DG
Diabetologia; 1998 Apr; 41(4):452-9. PubMed ID: 9562350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
